Bottom line
How much do XBI and FBDIX overlap?
18% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 7.4% of XBI's assets and 12.3% of FBDIX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings XBI and FBDIX have in common
| Holding | % of XBI | % of FBDIX | Overlap |
|---|---|---|---|
| Oruka Therapeutics Inc | 1.38% | 1.86% | 1.38% |
| Praxis Precision Medicines Inc | 1.29% | 1.91% | 1.29% |
| Revolution Medicines Inc | 1.20% | 3.01% | 1.20% |
| Dianthus Therapeutics Inc | 1.18% | 2.32% | 1.18% |
| Cytokinetics Inc | 1.18% | 1.24% | 1.18% |
| Mirum Pharmaceuticals Inc | 1.16% | 1.98% | 1.16% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XBI
- State Street Global Advisors — 5.87%
- Apogee Therapeutics Inc — 1.49%
- Moderna Inc — 1.41%
- Twist Bioscience Corp — 1.41%
- Kymera Therapeutics Inc — 1.36%
- Viking Therapeutics Inc — 1.30%
- Erasca Inc — 1.27%
- Rhythm Pharmaceuticals Inc — 1.20%
- CG oncology Inc — 1.20%
- SELLAS Life Sciences Group Inc — 1.19%
- Vaxcyte Inc — 1.19%
- Natera Inc — 1.16%
- Scholar Rock Holding Corp — 1.16%
- Roivant Sciences Ltd — 1.16%
- Cogent Biosciences Inc — 1.14%
Only in FBDIX
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
- Insmed, Inc. — 1.99%
- Spyre Therapeutics, Inc. — 1.87%
- Neurocrine Biosciences, Inc. — 1.82%
- Bridgebio Pharma, Inc. — 1.67%
- PTC Therapeutics, Inc. — 1.65%
- AstraZeneca plc — 1.51%
Asset mix
| Asset type | XBI | FBDIX |
|---|---|---|
| Stocks | 99.9% | 97.0% |
| Cash & short-term funds | 5.9% | 4.6% |
| Preferred stock | — | 1.0% |
| Other | — | 0.6% |
| Equity derivatives | 0.1% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | XBI | FBDIX |
|---|---|---|
| US | 100.8% | 82.0% |
| IE | 1.2% | 6.7% |
| NL | 1.0% | 4.5% |
| DK | — | 2.6% |
| FR | — | 1.7% |
| GB | — | 1.5% |
| CA | 0.2% | 1.3% |
| CH | 1.0% | 1.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do XBI and FBDIX overlap?
What stocks do XBI and FBDIX have in common?
Should I own both XBI and FBDIX?
Which holds more stocks, XBI or FBDIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.